Newsroom
Press Releases
July 13, 2021
WCG Acquires Intrinsic Imaging, Leading Full-Service Medical Imaging Core Lab
WCG announced the acquisition of Intrinsic Imaging, a leading global provider of medical imaging core lab services, enriching WCG's scientific and regulatory capabilities across drug, medical device and AI clinical trials.
Read more →March 1, 2021
Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations
Intrinsic Imaging's third FDA Bioresearch Monitoring Program (BIMO) inspection concluded with zero 483 observations — its third inspection with no findings.
Read more →February 26, 2019
Intrinsic Imaging Undergoes Extensive FDA BIMO Inspection — Receives Zero 483 Observations
A 5-day high-priority FDA BIMO inspection related to a pivotal BLA in advanced epithelial cancers concluded with full compliance and zero 483 observations.
Read more →January 11, 2018
Leading Artificial Intelligence Company Selects Intrinsic Imaging to Conduct Pivotal Clinical Trial
A leading AI company selected Intrinsic Imaging to conduct its pivotal MRMC trial in support of an FDA submission — Intrinsic's 15th AI clinical trial.
Read more →September 26, 2017
Intrinsic Imaging Selected by Emerging AI Company for Pivotal Medical Device Clinical Trial
Intrinsic Imaging was selected by an emerging AI company to assess clinical performance of novel AI software detecting musculoskeletal pathology — its 12th AI/DL/CAD MRMC trial.
Read more →August 15, 2017
Intrinsic Imaging Awarded Its Tenth CAD / AI / DL Clinical Trial
Intrinsic Imaging announced the award of its tenth MRMC clinical trial evaluating computer-aided detection, artificial intelligence and deep learning software in support of an FDA submission.
Read more →July 6, 2017
Intrinsic Imaging Awarded New Clinical Study to Evaluate Innovative Tumor Imaging Platform
A Phase II clinical trial to evaluate a novel imaging platform that assists physicians in distinguishing malignant from non-malignant tissue.
Read more →June 27, 2017
Intrinsic Imaging Awarded Validation Study for Innovative GI Motility Medical Device
Intrinsic Imaging awarded a validation study for an innovative medical device designed to aid in the evaluation of gastrointestinal motility.
Read more →March 9, 2017
Intrinsic Imaging Attains ISO 27001 Information Security Certification
Intrinsic Imaging's quality management system attained ISO 27001 certification, demonstrating its ability to protect informational assets across clinical trials.
Read more →September 9, 2016
Intrinsic Imaging Appoints Bryan Wayne as Vice President, Imaging Operations
Bryan Wayne, BSc., a senior imaging operations leader formerly with PAREXEL, joins Intrinsic Imaging as Vice President of Imaging Operations.
Read more →June 4, 2016
Intrinsic Imaging Awarded International Phase III Trial for NSCLC Brain Metastases
Intrinsic Imaging awarded a global Phase III clinical trial investigating a novel approach to treat Non-Small Cell Lung Cancer brain metastases.
Read more →May 19, 2016
Intrinsic Imaging Sponsors Webinar: The Advantages of an ISO Certified Quality Management System
Todd Joron leads a webinar on the advantages of an ISO 9001, 13485 and 22301 certified quality management system designed for clinical and medical device imaging.
Read more →March 20, 2016
Clinical Trial Sponsors Unanimously Agree Intrinsic Imaging Provides Exceptional Quality
Intrinsic Imaging's 2015 annual customer satisfaction survey: sponsors unanimously reported exceptional quality across every aspect of the company's services.
Read more →March 1, 2016
Todd Joron to Speak at Imaging in Clinical Trials, March 29–30 in Philadelphia
Todd Joron, President & COO, will present "Medical Imaging — Advantages of an ISO Certified Quality Management System" at Imaging in Clinical Trials.
Read more →April 23, 2015
Intrinsic Imaging Awarded Medical Device Trial for Percutaneous Tumor Ablation
A clinical trial to study an interventional medical device designed for the percutaneous ablation of cancerous tumors.
Read more →April 9, 2015
Intrinsic Imaging Awarded Phase II Clinical Trial for Glioblastoma Multiforme
Intrinsic Imaging awarded a Phase II clinical trial evaluating a novel treatment for patients with Glioblastoma Multiforme.
Read more →March 31, 2015
Intrinsic Imaging Awarded Phase II Clinical Trial for Advanced Squamous Cell Carcinoma
An international Phase II clinical trial to assess a new treatment for patients with advanced squamous cell carcinoma (SCC).
Read more →March 3, 2015
Intrinsic Imaging Awarded Interventional Medical Device Trial for Prevention of Pulmonary Emboli
Intrinsic Imaging awarded a clinical trial to evaluate an interventional medical device designed for the prevention of pulmonary emboli.
Read more →September 2, 2014
Intrinsic Imaging Expands Its Medical Imaging Consulting Group for Clinical Trials
Intrinsic Imaging expanded its Medical Imaging Consultancy Group to more than 65 full-time board-certified fellowship-trained radiologists.
Read more →August 21, 2014
Intrinsic Imaging Awarded International Phase II Study for Novel Vascular Medical Device
An international Phase II study for a novel vascular medical device, with comprehensive imaging core lab services and specialized radiologic review.
Read more →March 31, 2014
Intrinsic Imaging Obtains ISO 22301:2012 Business Continuity Management System Certification
Intrinsic Imaging obtained ISO 22301:2012 certification, demonstrating its ability to protect against, prepare for, respond to and recover from disruptive incidents.
Read more →February 12, 2014
Intrinsic Imaging Awarded Clinical Study for Novel Neurointerventional Medical Device
A clinical study for a novel neurointerventional medical device, with specialized review by board-certified interventional neuroradiologists.
Read more →September 18, 2013
Intrinsic Imaging Undergoes Extensive Quality Audit — Receives Zero Observations
Intrinsic Imaging underwent an extensive ISO audit by BSI and was found in complete compliance with ISO 9001:2008 and ISO 13485 with zero observations or recommendations.
Read more →August 13, 2013
Intrinsic Imaging Awarded Multi-Center Study for a Novel Vascular Medical Device
Intrinsic Imaging awarded a multi-center study for a novel vascular medical device, providing comprehensive imaging core lab services and specialized radiologic review.
Read more →September 26, 2012
BSI Awards ISO 13485:2003 Quality Certification to Intrinsic Imaging
BSI awarded Intrinsic Imaging ISO 13485:2003 certification for its ability to provide medical imaging core lab services meeting customer and regulatory requirements.
Read more →May 24, 2011
Intrinsic Imaging Joins Metastatic Colorectal Cancer Trial
Intrinsic Imaging will participate in a five-year multicenter clinical trial in metastatic colorectal cancer, providing imaging core lab services and oncology-subspecialized radiologists.
Read more →May 9, 2011
Omnicare to Employ Merge Clinical Trial Imaging Application — Featuring Intrinsic Imaging
Omnicare Clinical Research will use Merge's CIMS platform together with AG Mednet image transfer and Intrinsic Imaging's radiology expertise to build a virtual imaging core lab solution.
Read more →July 1, 2010
Intrinsic Imaging: Radiology Experts Launch Novel Medical Imaging CRO for Clinical Trials
A group of medical imaging experts, including radiologists from South Texas Radiology Group, launched Intrinsic Imaging — an advanced medical imaging contract research organization for clinical trials.
Read more →